Reduced RAGE levels have been observed in human IPF lungs (Ohlmeier et al., 2010) and animal models of pulmonary fibrosis (Englert et al., 2011; Ramsgaard et al., 2010), highlighting its role in disease progression. This evidence concerns the gene AGER and pulmonary fibrosis.